MedTrace Logo

Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry

NCT05914441 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-05-29

No results posted yet for this study

Summary

REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated.

The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.

Conditions

  • Purpura, Thrombocytopenic

Interventions

OTHER

Standard clinical practice

The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.

Sponsors & Collaborators

  • Fundación Española de Hematología y Hemoterapía

    lead OTHER

Principal Investigators

  • Dr. María Eva Mingot Castellano, M.D. Ph.D. · Hospital Universitario Virgen del Rocío. Sevilla, España.

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-22
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05914441 on ClinicalTrials.gov